The UK government has allotted £30m ($36m) to the NHS for medtech innovation ahead of winter. The investment is aimed at modernising technology, reducing waiting times, speeding up diagnosis, and enhancing patient treatment, including cybersecurity. However, the manner in which this fund will be distributed remains a concern, particularly due to the NHS’s annual funding cycle and rapid procurement, which often doesn’t lead to strategic acquisitions.
Canada loses its measles elimination status, and the US is close behind
Canada has lost its measles elimination status nearly three decades after it achieved the distinction, under circumstances that closely resemble what’s happened in the U.S.
